JP Patent

JP7732668B2 — 窒素含有多環式縮合環系化合物、その薬学的組成物、製造方法及び用途

Assigned to APPLIED PHARMACEUTICAL SCIENCE Inc · Expires 2025-09-02 · 1y expired

What this patent protects

Patent listed against Retevmo.

Drugs covered by this patent

Retevmo (SELPERCATINIB) · Eli Lilly

Patent Metadata

Patent number: JP7732668B2
Jurisdiction: JP
Classification: —
Expires: 2025-09-02
Drug substance claim: No
Drug product claim: No
Assignee: APPLIED PHARMACEUTICAL SCIENCE Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.